Is high VLDL linked to high triglycerides?

Yes, high VLDL and high triglycerides are directly linked because VLDL particles carry most of your blood triglycerides. When triglyceride levels rise above 150 mg/dL, your liver produces more VLDL particles to transport them, creating a cycle that increases cardiovascular disease risk.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the VLDL-Triglyceride Connection

Very low-density lipoprotein (VLDL) and triglycerides share an intimate relationship that directly impacts your cardiovascular health. VLDL particles are produced by your liver and serve as the primary carriers of triglycerides in your bloodstream. In fact, triglycerides make up about 50-65% of each VLDL particle's composition, making these two biomarkers inseparable when it comes to understanding your metabolic health.

When your triglyceride levels increase, your liver responds by producing more VLDL particles to transport these fats throughout your body. This creates a direct correlation: as triglycerides rise, so does VLDL cholesterol. Understanding this relationship is crucial for managing your cardiovascular risk and optimizing your metabolic health through regular monitoring.

What Are VLDL and Triglycerides?

VLDL Cholesterol Explained

VLDL cholesterol is one of the five major types of lipoproteins that transport fats and cholesterol through your bloodstream. Produced in your liver, VLDL particles are larger and less dense than LDL (low-density lipoprotein) particles. Their primary job is to deliver triglycerides from your liver to your tissues for energy use or storage.

VLDL and Triglyceride Level Classifications

BiomarkerOptimalNormalBorderline HighHigh
TriglyceridesTriglycerides (mg/dL)<100<150150-199≥200
VLDL CholesterolVLDL Cholesterol (mg/dL)<20<3030-40>40
Cardiovascular RiskAssociated CV RiskLowestLowModerateHigh

VLDL cholesterol is calculated as triglycerides ÷ 5. Both markers should be evaluated together for comprehensive cardiovascular risk assessment.

As VLDL particles circulate through your bloodstream and deliver their triglyceride cargo, they gradually become smaller and denser, eventually transforming into LDL particles. This transformation process is why VLDL is sometimes referred to as a precursor to LDL cholesterol, the type most strongly associated with atherosclerosis and heart disease.

Triglycerides: Your Body's Energy Currency

Triglycerides are the most common type of fat in your body, serving as a crucial energy source. When you eat, your body converts excess calories into triglycerides and stores them in fat cells. Between meals, hormones trigger the release of these triglycerides to provide energy. While this system is essential for normal function, problems arise when triglyceride levels become chronically elevated.

Normal triglyceride levels should be below 150 mg/dL, with optimal levels under 100 mg/dL. When levels exceed 150 mg/dL, you enter the borderline high range, and levels above 200 mg/dL are considered high. Very high triglycerides (above 500 mg/dL) significantly increase your risk of pancreatitis and require immediate medical attention.

The Science Behind Their Connection

The relationship between VLDL and triglycerides is rooted in their biological structure and function. Each VLDL particle contains a core of triglycerides surrounded by a shell of phospholipids, cholesterol, and proteins called apolipoproteins. The apolipoprotein B-100 (ApoB) on each VLDL particle acts like a shipping label, directing the particle to its destination.

When you consume excess calories, particularly from carbohydrates or alcohol, your liver increases triglyceride production. To transport these triglycerides, your liver must produce more VLDL particles. This is why dietary factors that raise triglycerides also increase VLDL levels. The process creates a measurable relationship: for every 88.5 mg/dL increase in triglycerides, VLDL cholesterol typically increases by about 17.7 mg/dL (since VLDL cholesterol is estimated as triglycerides divided by 5).

This biochemical connection explains why treating high triglycerides often simultaneously reduces VLDL levels. Medications like fibrates, omega-3 fatty acids, and niacin work by reducing the liver's triglyceride production, which in turn decreases VLDL synthesis. Similarly, lifestyle interventions that lower triglycerides naturally reduce VLDL cholesterol.

Health Implications of Elevated VLDL and Triglycerides

Cardiovascular Disease Risk

High VLDL and triglyceride levels significantly increase your risk of cardiovascular disease through multiple mechanisms. VLDL particles can penetrate arterial walls and become oxidized, triggering inflammation and plaque formation. Additionally, high triglycerides are associated with smaller, denser LDL particles that are more atherogenic (plaque-forming) than larger LDL particles.

Research shows that elevated triglycerides independently predict cardiovascular events, even after accounting for LDL cholesterol levels. A meta-analysis of 61 studies found that each 88.5 mg/dL increase in triglycerides was associated with a 22% increased risk of cardiovascular disease. This risk is particularly pronounced when triglycerides exceed 200 mg/dL.

Metabolic Syndrome and Diabetes

High VLDL and triglycerides are core components of metabolic syndrome, a cluster of conditions that includes abdominal obesity, high blood pressure, elevated blood sugar, and abnormal cholesterol levels. This syndrome affects about one-third of American adults and significantly increases the risk of Type 2 diabetes and heart disease.

The connection between high triglycerides and insulin resistance creates a vicious cycle. Insulin resistance causes the liver to produce more VLDL particles, while high triglycerides worsen insulin sensitivity. This relationship explains why people with Type 2 diabetes often have a lipid profile characterized by high triglycerides, high VLDL, low HDL cholesterol, and small, dense LDL particles.

Common Causes of High VLDL and Triglycerides

Understanding what drives elevated VLDL and triglycerides can help you take targeted action to improve your levels. The most common causes include:

  • Dietary factors: Excessive intake of refined carbohydrates, added sugars, and alcohol
  • Obesity: Particularly abdominal obesity, which increases liver fat and VLDL production
  • Physical inactivity: Sedentary behavior reduces the muscles' ability to clear triglycerides
  • Genetic factors: Familial hypertriglyceridemia and other inherited conditions
  • Medical conditions: Diabetes, hypothyroidism, kidney disease, and liver disease
  • Medications: Beta-blockers, thiazide diuretics, estrogen, and corticosteroids
  • Lifestyle factors: Smoking, excessive stress, and poor sleep quality

Among dietary factors, fructose consumption deserves special attention. High fructose intake, particularly from sugar-sweetened beverages, directly stimulates liver triglyceride production. Studies show that consuming 25% of calories from fructose can increase fasting triglycerides by 37% and post-meal triglycerides by 48% within just two weeks.

Testing and Monitoring Your Levels

Standard Lipid Panel Testing

A standard lipid panel measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. VLDL cholesterol is typically calculated using the Friedewald equation: VLDL = Triglycerides ÷ 5. This calculation works well when triglycerides are below 400 mg/dL but becomes less accurate at higher levels. For the most accurate results, you should fast for 9-12 hours before testing.

However, standard lipid panels have limitations. They don't measure VLDL directly and may miss important risk factors like small, dense LDL particles or lipoprotein(a). Advanced lipid testing, including apolipoprotein B (ApoB) measurement, provides a more comprehensive assessment of cardiovascular risk.

Optimal Testing Frequency

Testing frequency depends on your baseline levels and risk factors. If your levels are optimal and you have no risk factors, annual testing may suffice. However, if you have elevated levels or are making lifestyle changes to improve them, testing every 3-6 months allows you to track progress and adjust your approach. Those with very high triglycerides (above 500 mg/dL) may need more frequent monitoring to prevent complications.

Natural Ways to Lower VLDL and Triglycerides

Dietary Modifications

Diet plays a crucial role in managing VLDL and triglyceride levels. The most effective dietary changes include:

  • Reduce refined carbohydrates and added sugars: Limit foods high in simple sugars and refined grains
  • Increase omega-3 fatty acids: Aim for 2-4 grams daily from fatty fish or supplements
  • Choose healthy fats: Replace saturated fats with monounsaturated and polyunsaturated fats
  • Increase fiber intake: Aim for 25-35 grams daily from whole grains, fruits, and vegetables
  • Limit alcohol: Even moderate alcohol intake can significantly raise triglycerides in sensitive individuals
  • Practice portion control: Excess calories from any source can raise triglycerides

The Mediterranean diet pattern has shown particular promise for improving triglyceride levels. Studies demonstrate that following a Mediterranean diet can reduce triglycerides by 10-15% while also improving other cardiovascular risk factors. This eating pattern emphasizes whole grains, fruits, vegetables, legumes, nuts, olive oil, and fish while limiting red meat and processed foods.

Exercise and Physical Activity

Regular physical activity is one of the most effective ways to lower triglycerides and VLDL cholesterol. Exercise works through multiple mechanisms: it increases lipoprotein lipase activity (which breaks down triglycerides), improves insulin sensitivity, and reduces liver fat accumulation. Both aerobic exercise and resistance training provide benefits.

Aim for at least 150 minutes of moderate-intensity aerobic exercise or 75 minutes of vigorous-intensity exercise weekly. High-intensity interval training (HIIT) may be particularly effective, with studies showing 20-30% reductions in triglycerides after 12-16 weeks of training. Even a single bout of exercise can temporarily lower triglycerides for up to 48 hours.

Weight Management and Lifestyle Factors

Weight loss, particularly reduction in abdominal fat, significantly improves VLDL and triglyceride levels. Even modest weight loss of 5-10% of body weight can reduce triglycerides by 20-30%. The benefits occur through reduced liver fat, improved insulin sensitivity, and decreased VLDL production.

Other important lifestyle factors include stress management and adequate sleep. Chronic stress increases cortisol levels, which can raise triglycerides and VLDL production. Poor sleep quality and duration are associated with higher triglyceride levels, with studies showing that getting less than 6 hours of sleep per night can increase triglycerides by 20-30%.

Taking Action for Better Metabolic Health

The strong connection between VLDL and triglycerides means that addressing one typically improves the other. This relationship simplifies your approach to cardiovascular health: focus on lowering triglycerides through diet, exercise, and lifestyle modifications, and your VLDL levels will follow. Regular monitoring helps you track progress and adjust your strategy as needed.

Remember that small, consistent changes often produce the best long-term results. Start with one or two modifications, such as reducing added sugars or adding a daily walk, then gradually build on your success. With the right approach and regular monitoring, you can optimize both your VLDL and triglyceride levels, significantly reducing your risk of cardiovascular disease and improving your overall metabolic health.

References

  1. Nordestgaard, B. G. (2016). Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circulation Research, 118(4), 547-563.[Link][PubMed][DOI]
  2. Miller, M., Stone, N. J., Ballantyne, C., et al. (2011). Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 123(20), 2292-2333.[Link][PubMed][DOI]
  3. Packard, C. J., & Shepherd, J. (1997). Lipoprotein heterogeneity and apolipoprotein B metabolism. Arteriosclerosis, Thrombosis, and Vascular Biology, 17(12), 3542-3556.[PubMed][DOI]
  4. Stanhope, K. L., Schwarz, J. M., Keim, N. L., et al. (2009). Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. Journal of Clinical Investigation, 119(5), 1322-1334.[PubMed][DOI]
  5. Sarwar, N., Danesh, J., Eiriksdottir, G., et al. (2007). Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation, 115(4), 450-458.[PubMed][DOI]
  6. Chapman, M. J., Ginsberg, H. N., Amarenco, P., et al. (2011). Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. European Heart Journal, 32(11), 1345-1361.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my VLDL and triglycerides at home?

You can test your VLDL and triglycerides at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive lipid testing with triglycerides, calculated VLDL cholesterol, and advanced markers like ApoB. The program provides CLIA-certified lab results with personalized insights to help you optimize your cardiovascular health.

What is the normal range for VLDL cholesterol?

Normal VLDL cholesterol levels typically range from 5-40 mg/dL. Since VLDL is calculated as triglycerides divided by 5, keeping triglycerides below 150 mg/dL usually ensures normal VLDL levels. Optimal VLDL is below 30 mg/dL, which corresponds to triglycerides under 150 mg/dL.

Can you have high VLDL without high triglycerides?

It's extremely rare to have high VLDL without high triglycerides because VLDL particles are primarily composed of triglycerides (50-65%). Since VLDL cholesterol is calculated from triglyceride levels, they almost always rise and fall together. If you see discordant results, it may indicate a lab error or a need for direct VLDL measurement.

How quickly can I lower my VLDL and triglycerides?

Triglycerides and VLDL can respond quickly to lifestyle changes. With dietary modifications and increased exercise, you may see improvements within 2-4 weeks. Significant reductions of 20-40% are possible within 8-12 weeks with consistent effort. Very high triglycerides (>500 mg/dL) may require medication for faster reduction.

What foods should I avoid if I have high VLDL and triglycerides?

Avoid foods high in refined carbohydrates, added sugars, and trans fats. Specifically limit sugar-sweetened beverages, white bread, pastries, candy, and fried foods. Alcohol should be minimized or avoided as it can significantly raise triglycerides. Focus instead on whole grains, lean proteins, healthy fats, and plenty of vegetables.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details